PMO Interview with the Innovator Series: Volume 6Video Categories: PMO Interview with the Innovator Series
Drs. David Rimm and Roy Herbst review the problems with the CMS â14-Day Ruleâ since some of the multigene panel biomarker tests require 21 days or longer to complete.
According to Alexander Bastian, it’s very difficult to determine how to integrate cost into the equation of cancer care. He explains that cost should be considered early on and uses Dr. Zafar’s term of financial toxicity, meaning the burden of cost can be as bad or worse than a physical [ Read More ]